Hims & Hers Health, Inc.
HIMSNYSEHealthcare● Active
$27.17
+$0.98(+3.74%)
Market Cap$6.1B
P/E Ratio—
52W High$70.43
52W Low$13.74
Hims & Hers Health, Inc. (HIMS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HIMS · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
-$0.18
Est. $0.04 · -550.0%
Revenue
$0.61B
Est. $0.62B · -1.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
HIMS reports quarterly as a NYSE-listed Medical - Equipment & Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 10, 2026 | -$0.02 | — | — | — | $0.69B | — |
| ▼ Q2 FY2026 | May 11, 2026 | $0.04 | -$0.18 | -550.0% | $0.61B | $0.62B | -1.4% |
| ▲ Q1 FY2026 | Feb 23, 2026 | $0.02 | $0.07 | +250.0% | $0.62B | $0.62B | -0.2% |
| ▼ Q4 FY2025 | Nov 3, 2025 | $0.09 | $0.06 | -33.3% | $0.60B | $0.62B | -3.1% |
| ▼ Q3 FY2025 | Aug 4, 2025 | $0.18 | $0.17 | -5.6% | $0.54B | $0.58B | -6.7% |
| ▲ Q2 FY2025 | May 5, 2025 | $0.12 | $0.20 | +65.4% | $0.59B | $0.54B | +8.8% |
| ▲ Q1 FY2025 | Feb 24, 2025 | $0.09 | $0.11 | +22.2% | $0.48B | $0.49B | -2.7% |
| — Q4 FY2024 | Nov 4, 2024 | $0.06 | $0.06 | +0.0% | $0.40B | $0.47B | -14.5% |
Q3 FY2026
Aug 10, 2026
EPS Actual
—
EPS Est.
-$0.02
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Miss
EPS Actual
-$0.18
EPS Est.
$0.04
EPS Surpr.
-550.0%
Revenue
$0.61B
Q1 FY2026
Feb 23, 2026Beat
EPS Actual
$0.07
EPS Est.
$0.02
EPS Surpr.
+250.0%
Revenue
$0.62B
Q4 FY2025
Nov 3, 2025Miss
EPS Actual
$0.06
EPS Est.
$0.09
EPS Surpr.
-33.3%
Revenue
$0.60B
Q3 FY2025
Aug 4, 2025Miss
EPS Actual
$0.17
EPS Est.
$0.18
EPS Surpr.
-5.6%
Revenue
$0.54B
Q2 FY2025
May 5, 2025Beat
EPS Actual
$0.20
EPS Est.
$0.12
EPS Surpr.
+65.4%
Revenue
$0.59B
Q1 FY2025
Feb 24, 2025Beat
EPS Actual
$0.11
EPS Est.
$0.09
EPS Surpr.
+22.2%
Revenue
$0.48B
Q4 FY2024
Nov 4, 2024
EPS Actual
$0.06
EPS Est.
$0.06
EPS Surpr.
+0.0%
Revenue
$0.40B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.34 | $0.35 | $0.37 | 3 |
| Q3 FY2028 | $0.37 | $0.38 | $0.41 | 3 |
| Q2 FY2028 | $0.16 | $0.17 | $0.18 | 3 |
| Q1 FY2028 | $-0.03 | $-0.03 | $-0.03 | 3 |
| Q4 FY2027 | $0.21 | $0.22 | $0.23 | 2 |
| Q3 FY2027 | $0.18 | $0.18 | $0.19 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $1.0B | $1.1B | $1.1B | 6 |
| Q3 FY2028 | $1.0B | $1.0B | $1.1B | 3 |
| Q2 FY2028 | $0.9B | $0.9B | $1.0B | 5 |
| Q1 FY2028 | $0.8B | $0.8B | $0.8B | 3 |
| Q4 FY2027 | $0.9B | $0.9B | $0.9B | 7 |
| Q3 FY2027 | $0.8B | $0.9B | $0.9B | 4 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 11, 2026 | -550.0% | $28.27 | $29.14 | +3.08% |
| ▲ Q1 FY2026 | Feb 23, 2026 | +250.0% | $15.63 | $15.51 | -0.77% |
| ▼ Q4 FY2025 | Nov 3, 2025 | -33.3% | $45.46 | $44.39 | -2.35% |
| ▼ Q3 FY2025 | Aug 4, 2025 | -5.6% | $62.55 | $63.35 | +1.28% |
| ▲ Q2 FY2025 | May 5, 2025 | +65.4% | $40.82 | $41.88 | +2.60% |
| ▲ Q1 FY2025 | Feb 24, 2025 | +22.2% | $49.28 | $51.31 | +4.12% |
| ▲ Q4 FY2024 | Nov 4, 2024 | +0.0% | $20.36 | $20.76 | +1.96% |
| ▲ Q3 FY2024 | Aug 5, 2024 | +40.4% | $17.58 | $17.84 | +1.48% |
Q2 FY2026+3.08%
Report Date
May 11, 2026
EPS Beat/Miss
-550.0%
Price Before
$28.27
Price After
$29.14
Q1 FY2026-0.77%
Report Date
Feb 23, 2026
EPS Beat/Miss
+250.0%
Price Before
$15.63
Price After
$15.51
Q4 FY2025-2.35%
Report Date
Nov 3, 2025
EPS Beat/Miss
-33.3%
Price Before
$45.46
Price After
$44.39
Q3 FY2025+1.28%
Report Date
Aug 4, 2025
EPS Beat/Miss
-5.6%
Price Before
$62.55
Price After
$63.35
Q2 FY2025+2.60%
Report Date
May 5, 2025
EPS Beat/Miss
+65.4%
Price Before
$40.82
Price After
$41.88
Q1 FY2025+4.12%
Report Date
Feb 24, 2025
EPS Beat/Miss
+22.2%
Price Before
$49.28
Price After
$51.31
Q4 FY2024+1.96%
Report Date
Nov 4, 2024
EPS Beat/Miss
+0.0%
Price Before
$20.36
Price After
$20.76
Q3 FY2024+1.48%
Report Date
Aug 5, 2024
EPS Beat/Miss
+40.4%
Price Before
$17.58
Price After
$17.84
Avg Beat Reaction+1.88%
Avg Miss Reaction+0.67%
Beat Rate5 / 8 quarters
Largest Move+4.12% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HIMS ends December
Hims & Hers Health, Inc. (HIMS) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $-0.18 — missing the analyst consensus of $0.04 by -550.0%. The next HIMS earnings date is expected around September 1, 2026.
Each quarter, investors track HIMS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HIMS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HIMS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HIMS earnings · 5 questionsHims & Hers Health, Inc.'s next earnings report is expected around September 1, 2026. HIMS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HIMS historically reports after market close (AMC).
HIMS earnings datewhen is HIMS earningsHIMS next earnings datewhen does HIMS report earningsHIMS earnings calendar
▸ Source: FMP · Hims & Hers Health, Inc. SEC filings · US GAAP · Hims & Hers Health, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026